{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:58:10Z","timestamp":1776131890894,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1124\/dmd.108.021790","type":"journal-article","created":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T00:54:48Z","timestamp":1218156888000},"page":"2219-2226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Hepatic Metabolism and Biliary Excretion of Silymarin Flavonolignans in Isolated Perfused Rat Livers: Role of Multidrug Resistance-Associated Protein 2 (Abcc2)"],"prefix":"10.1016","volume":"36","author":[{"given":"Sonia R.","family":"Miranda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim L.R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiming","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy L.","family":"Hawke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.108.021790_bib1","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1124\/dmd.107.016170","article-title":"Induction of hepatobiliary efflux transporters in acetaminophen-induced acute liver failure cases","volume":"35","author":"Barnes","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"Suppl 1","key":"10.1124\/dmd.108.021790_bib2","first-page":"363A","article-title":"Silymarin down-regulates HCV core and up-regulates hemeoxygenase-1 gene in expression in the CNS3 replicon line of human liver cells","volume":"46","author":"Bonifaz","year":"2007","journal-title":"Hepatology"},{"key":"10.1124\/dmd.108.021790_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4899-1863-5_10","article-title":"Isolated perfused liver","volume":"8","author":"Brouwer","year":"1996","journal-title":"Pharm Biotechnol"},{"key":"10.1124\/dmd.108.021790_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2174\/138920006778520570","article-title":"The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms","volume":"7","author":"Cermak","year":"2006","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.108.021790_bib5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2174\/092986706776360950","article-title":"Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication","volume":"13","author":"Crocenzi","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1124\/dmd.108.021790_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10637-006-9019-2","article-title":"A phase I and pharmacokinetic study of silybin-phytosome in prostrate cancer patients","volume":"25","author":"Flaig","year":"2007","journal-title":"Invest New Drugs"},{"key":"10.1124\/dmd.108.021790_bib7","first-page":"614","article-title":"Plasma concentrations of free and conjugated silbin after oral intake of a siybin-phosphatidylcholine complex (silipide) in healthy volunteers","volume":"32","author":"Gatti","year":"1994","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/dmd.108.021790_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.1840060331","article-title":"The isolated perfused rat liver: conceptual and practical considerations","volume":"6","author":"Gores","year":"1986","journal-title":"Hepatology"},{"key":"10.1124\/dmd.108.021790_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1570-0232(03)00484-7","article-title":"Application of liquid chromatography-electrospray ionization-ion trap mass spectrometry to investigate the metabolism of silibinin in human liver microsomes","volume":"794","author":"Gunaratna","year":"2003","journal-title":"J Chromatogr B"},{"key":"10.1124\/dmd.108.021790_bib10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0168-8278(01)00216-1","article-title":"Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis virus C infection","volume":"35","author":"Hinoshita","year":"2001","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.108.021790_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1081\/DMR-200033473","article-title":"The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance","volume":"36","author":"Hoffmann","year":"2004","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.108.021790_bib12","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1124\/dmd.107.016410","article-title":"Silybin is metabolized by cytochrome P450 2C8 in vitro","volume":"35","author":"Jan\u010dov\u00e1","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.021790_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.1840050408","article-title":"Hereditary chronic conjugated hyperbiliru-binemia in mutant rats caused by defective hepatic anion transport","volume":"5","author":"Jansen","year":"1985","journal-title":"Hepatology"},{"key":"10.1124\/dmd.108.021790_bib14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/dmd.105.005793","article-title":"Characterization of transport protein expression in multidrug resistance associated protein (MRP)2-deficient rats","volume":"34","author":"Johnson","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.021790_bib15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/00498250310001602720","article-title":"Metabolism and disposition of gemfibrozil in wistar and multidrug resistance-associated protein 2-deficient TR-rats","volume":"33","author":"Kim","year":"2003","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.108.021790_bib16","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1039\/b300099k","article-title":"Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum)","volume":"1","author":"Kim","year":"2003","journal-title":"Org Biomol Chem"},{"key":"10.1124\/dmd.108.021790_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0005-2736(99)00169-8","article-title":"Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance","volume":"1461","author":"K\u00f6nig","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.108.021790_bib18","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.lfs.2005.04.005","article-title":"Modulation of MRP1 protein transport by plant, and synthetically modified flavonoids","volume":"77","author":"Lania-Pietrzak","year":"2005","journal-title":"Life Sci"},{"key":"10.1124\/dmd.108.021790_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1124\/dmd.106.013946","volume":"35","author":"Luo","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.021790_bib20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/jps.21057","article-title":"Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides","volume":"97","author":"Maier-Salamon","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.108.021790_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2893.2005.00636.x","article-title":"Silymarin treatment of viral hepatitis: a systematic review","volume":"12","author":"Mayer","year":"2005","journal-title":"J Viral Hepat"},{"key":"10.1124\/dmd.108.021790_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-5793(01)02916-7","article-title":"Biliary excretion of a stretched bilirubin in UGT1A1-deficient (Gunn) and MRP2 deficient (TR-) rats","volume":"506","author":"McDonagh","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1124\/dmd.108.021790_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF03189986","article-title":"Comparative bioavailability of silipide, a new flavanolignan complex, in rats","volume":"17","author":"Morazzoni","year":"1992","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.108.021790_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF03188811","article-title":"Comparative pharmacokinetics of silipide and silymarin in rats","volume":"18","author":"Morazzoni","year":"1993","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.108.021790_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jps.10283","article-title":"Effects of flavonoids on MRP1-mediated transport in Panc-1 cells","volume":"92","author":"Nguyen","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.108.021790_bib26","doi-asserted-by":"crossref","first-page":"G438","DOI":"10.1152\/ajpgi.2000.278.3.G438","article-title":"Characterization of inducible nature of MRP3 in rat liver","volume":"278","author":"Ogawa","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/dmd.108.021790_bib27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/hep.510250635","article-title":"A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome","volume":"25","author":"Paulusma","year":"1997","journal-title":"Hepatology"},{"key":"10.1124\/dmd.108.021790_bib28","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1053\/j.gastro.2007.02.038","article-title":"Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized silymarin","volume":"132","author":"Polyak","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.108.021790_bib29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/path.1379","article-title":"High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe liver disease","volume":"200","author":"Ros","year":"2003","journal-title":"J Pathol"},{"key":"10.1124\/dmd.108.021790_bib30","first-page":"964","article-title":"Pharmacokinetics of silybin in bile flowing administration of silipide and silymarin in cholecystectomy patients","volume":"42","author":"Schandalik","year":"1992","journal-title":"Drug Res"},{"key":"10.1124\/dmd.108.021790_bib31","article-title":"Phase I study to evaluate the safety, tolerability, and pharmacokinetics of silymarin following chronic dosing in patients with chronic hepatitis C","volume":"134","author":"Schrieber","year":"2008","journal-title":"Gastroenterology S"},{"key":"10.1124\/dmd.108.021790_bib32","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1124\/dmd.107.019604","article-title":"The pharmacokinetics of silymarin is altered in patients with chronic hepatitis c virus and nonalcoholic fatty liver disease and correlates with plasma caspase-3\/7 activity","volume":"36","author":"Schrieber","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.021790_bib33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep.22044","article-title":"Herbal product use by persons enrolled in the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial","volume":"47","author":"Seeff","year":"2008","journal-title":"Hepatology"},{"key":"10.1124\/dmd.108.021790_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bcp.2007.04.002","article-title":"The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential","volume":"74","author":"van Zanden","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.108.021790_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/dmd.107.017566","article-title":"Pharmacokinetics and metabolic profile of free, conjugated and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract","volume":"36","author":"Wen","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.021790_bib36","first-page":"134","article-title":"Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay","volume":"30","author":"Weyhenmeyer","year":"1992","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1124\/dmd.108.021790_bib37","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1111\/j.1742-4658.2005.04888.x","article-title":"Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5)","volume":"272","author":"Wu","year":"2005","journal-title":"FEBS J"},{"key":"10.1124\/dmd.108.021790_bib38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/dmd.107.017004","article-title":"Hepatobiliary excretion of silibinin in normal and liver cirrhotic rats","volume":"36","author":"Wu","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.021790_bib39","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1124\/dmd.30.9.962","article-title":"Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment","volume":"30","author":"Xiong","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.021790_bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.106.101840","article-title":"Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat","volume":"319","author":"Zamek-Gliszczynski","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.108.021790_bib41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejps.2005.12.007","article-title":"Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites","volume":"27","author":"Zamek-Gliszczynski","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.108.021790_bib42","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1124\/dmd.104.002188","article-title":"Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of MRP2 and BCRP1","volume":"33","author":"Zamek-Gliszczynski","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.108.021790_bib43","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1023\/A:1025044913766","article-title":"Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells","volume":"20","author":"Zhang","year":"2003","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.108.021790_bib44","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1023\/B:PHAM.0000033015.84146.4c","article-title":"Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport","volume":"21","author":"Zhang","year":"2004","journal-title":"Pharm Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624018403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624018403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.108.021790","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:30:30Z","timestamp":1739896230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624018403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0090955624018403"],"URL":"https:\/\/doi.org\/10.1124\/dmd.108.021790","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic Metabolism and Biliary Excretion of Silymarin Flavonolignans in Isolated Perfused Rat Livers: Role of Multidrug Resistance-Associated Protein 2 (Abcc2)","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.108.021790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}